spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Sexually Transmitted Disease (STD) Self-Testing Market Trends, Analysis & Forecasts by Segment, Application to 2029

The Business Research Company’s Sexually Transmitted Disease (STD) Self-Testing Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

What Is The Estimated Industry Size Of Sexually Transmitted Disease (STD) Self-Testing Market?

In recent times, the market size of self-testing for sexually transmitted diseases (STDs) has experienced swift growth. It’s projected to expand from $1.38 billion in 2024 to $1.52 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. The growth witnessed in the past can be linked to factors such as increased awareness on sexual health, a surge in the utilization of home-based healthcare services, increased government-led STD testing campaigns, the growing availability of self-test kits that can be purchased over the counter, and escalating concerns related to privacy when testing in clinical settings.

The market for self-testing of sexually transmitted diseases (STD) is predicted to experience significant expansion in the upcoming years, expected to reach $2.21 billion in 2029 with a compound annual growth rate (CAGR) of 9.8%. Factors contributing to the anticipated growth in the forecast period involve the rising incidence of STDs, increased demand for convenient and private testing alternatives, the uptrend in blending digital health into self-test kits, broader access to home-based diagnostics in developing markets, and an escalated approval rate of superior self-testing technologies by regulatory agencies. Key trends expected during the forecast period encompass advancements in swift molecular diagnostic technologies, advanced integration of mobile applications for monitoring results, the evolution of self-test kits that can diagnose multiple infections, improvements in discreet packaging and delivery systems, and progress in artificial intelligence-powered interpretation of testing outcomes.

Hot this week

Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation

Daewoong Pharmaceutical said on October 17 that it met...

Novo Nordisk chair and independent directors to exit in strategy dispute

The chair of Wegovy maker Novo Nordisk and six...

Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG

Medical diagnostics firm Hologic has agreed to be acquired...

China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda

-China’s Innovent Biologics said on Wednesday it had signed...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img